Glaucoma is often called the “silent thief of sight” because the disease can damage vision for years before people notice ...

Studies show that GLP-1 receptor agonists have significant potential for treating glaucoma, diabetic retinopathy and other ...

Charisse Brown, a 38-year-old Columbia, S.C., resident, talks about her journey with glaucoma and keratoconus, which led to vision loss in her left eye. Underinsured and not qualifying for Medicaid, ...

Glaucoma videos on social media may promote dangerous, unproven treatment options and frequently do not discuss any risks ...

As glaucoma management evolves toward earlier intervention, the question of when and how to escalate treatment remains ...

In glaucoma patients, sleeping with two stacked pillows was linked to slightly higher intraocular pressure (IOP) compared to sleeping with no pillows. The findings of the observational study ...

A major international study led by Flinders University has identified a genetic contributor to juvenile glaucoma. Published today in the journal JAMA Ophthalmology, the study marks another important ...

A headache is a common occurrence for many of us, but for Effie Iemma , it was the first sign that she had glaucoma. "I had an eye test, just my normal routine eye ...

Many patients come in for an eye examination that they have been delaying for years, and we often discover severe glaucoma to an extent that treatment options are very limited. The damage is often so ...

Ocular Therapeutix delivers ophthalmic therapies with hydrogel technology and a pipeline targeting retinal and glaucoma ...

Synakis Corp., a Toronto-based biotechnology company developing ocular therapies for retinal disease and glaucoma, announced today the close of an oversubscribed CAD $2.6 million pre-seed financing ...